NCT02246166View on ClinicalTrials.gov

The Effect of Paracetamol, Pseudoephedrine Hydrochloride, Dextromethorphan Hydrobromide and Chlorpheniramine Maleate Tablets Compared to Placebo in Subjects Suffering From the Common Cold or Influenza.

PHASE4CompletedINTERVENTIONAL
Enrollment

53

Participants

Timeline

Start Date

January 31, 2015

Primary Completion Date

February 28, 2015

Study Completion Date

February 28, 2015

Conditions
Common Cold
Interventions
DRUG

Test tablet

The active tablet will be administered orally. Product administration will occur within 30mins of the baseline assessment of symptom severity

OTHER

Placebo

The placebo tablet will be administered orally. Product administration will occur within 30mins of the baseline assessment of symptom severity

Trial Locations (2)

200025

GSK Investigational Site, Shanghai

200120

GSK Investigational Site, Shanghai

Sponsors

Lead Sponsor

GlaxoSmithKline
All Listed Sponsors
collaborator

Sino-American Tianjin Smith Kline & French Laboratories Ltd

UNKNOWN

lead

GlaxoSmithKline

INDUSTRY

NCT02246166 - The Effect of Paracetamol, Pseudoephedrine Hydrochloride, Dextromethorphan Hydrobromide and Chlorpheniramine Maleate Tablets Compared to Placebo in Subjects Suffering From the Common Cold or Influenza. | Biotech Hunter | Biotech Hunter